← All trials
NCT05255484
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- May 26, 2022
- Primary completion
- Jul 31, 2024
- Completion date
- Sep 14, 2024
- First posted
- Feb 24, 2022
- Last posted
- Jun 2, 2022
- Enrollment
- 54
- Arms / groups
- 4 / —
- Source
- AACT · ctgov ingestion
Sponsors
- LaNova Medicines LimitedLead sponsor
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.